Long

NBRV Technical Analysis 🧙

Aggiornato
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections.

If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Trade attivo
got first take profit om pre-market
Trade chiuso: obiettivo raggiunto
got second take profit on premarket
NBRVPivot PointsstocksignalsSupply and DemandSupport and Resistancetoptraderyuriidomaranskyi

Anche su:

Declinazione di responsabilità